ClinicalTrials.gov Search

Search for specific clinical trials that are underway using the keyword search below.

Keywords:

Patient support groups also offer information about clinical trials.

Content Provided By

NINDS Disorders is an index of neurological conditions provided by the National Institute of Neurological Disorders and Stroke. This valuable tool offers detailed descriptions, facts on treatment and prognosis, and patient organization contact information for over 500 identified neurological disorders.

Neurology Now
Business as (Mostly) Usual: Multiple sclerosis hasn't stopped Fox Anchor Neil Cavuto from doing what he loves. 09.01.2012
Business as (Mostly) Usual: Multiple sclerosis hasn't stopped Fox Anchor Neil Cavuto from doing what he loves. 09.01.2012
Ask the Experts: Multiple sclerosis 07.01.2012
Speak Up: Superwoman in Slow Motion 07.01.2012
Learning to manage the fatigue of multiple sclerosis 02.01.2012
This Way In: The Cost of MS Drugs 12.01.2011
Neurology News: Raising awareness of Parkinson's and multiple sclerosis. 10.01.2011
Letters: Dreaming With Multiple Sclerosis 06.01.2011
Neurology News: New Web Site for MS Therapies 04.01.2011
Give and Take: Multiple sclerosis has taken so much, but also given me precious gifts. 02.01.2011
Ask the Experts: Multiple Sclerosis and Depression 11.01.2010
A Punk Rock Icon Takes on MS 09.01.2010
RESOURCE CENTRAL: The Bookshelf: Multiple Sclerosis 09.01.2010
This Way In: CCSVI and Multiple Sclerosis 07.01.2010
Neurology News: Just Diagnosed With Multiple Sclerosis? 07.01.2010
This Way In: CCSVI and Multiple Sclerosis 07.01.2010
Neurology News: Just Diagnosed With Multiple Sclerosis? 07.01.2010
New Imaging Captures the Brain's Complexity 05.01.2010
Color Confusion 05.01.2010
NEW FRONTIERS: Oral Drugs for MS 05.01.2010
Letters: Multiple Sclerosis and Your Bones 03.01.2010
Boning Up On Multiple Sclerosis. 01.01.2010
Quick Tips: Multiple Sclerosis. 09.01.2009
Adding a Steroid to MS Drugs. 07.01.2009
Bittersweet Symphony: With gratitude and hope, acclaimed singer-songwriter and MS sufferer Victoria Williams faces the music.. 07.01.2009
Multiple Sclerosis. 05.01.2009
NEUROLOGY NEWS: Multiple Sclerosis and Smoking Risk. 05.01.2009
Pictures of You. 05.01.2009
Multiple Sclerosis. 01.01.2009
Hitting the Mattress with MS. 01.01.2009
Maximize Your Drug Plan. 11.01.2008
Accepting Multiple Sclerosis. 11.01.2008
MULTIPLE SCLEROSIS THERAPIES. 09.01.2008
Neuro Blogs. 07.01.2008
Compassionate Minds. 07.01.2008
Transportation Options. 07.01.2008
Healing Touch. 05.01.2008
Mindful Of Pain. 11.01.2007
Off the Couch With Dr. Katz. 09.01.2007
What the Nose Knows. 09.01.2007
MS and Relationships. 07.01.2007
Living in Denial. 07.01.2007
Freedom from disease activity in multiple sclerosis 05.01.2007
Sex, Love, and Multiple Sclerosis. 05.01.2007
Cool Down MS. 05.01.2007
Multiple sclerosis. 03.01.2007
Your Questions Answered: MULTIPL ESCLEROSIS PROGRESSION. 03.01.2007
The Winning Spirit to Beat MS Odds. 11.01.2006
Beating the Odds. 07.01.2006
Sittin' Pretty, Country Style: Clay Walker plays on to keep his MS in check and his songs atop the charts. 01.01.2006
Uphill Racer: Olympic ski hero Jimmie Heuga blazes another trail: An active way to wellness for fellow MS patients. 01.01.2006
AAN Press Releases
Researchers Investigating New Treatment for Multiple Sclerosis 08.27.2014
Guideline: Medical Marijuana in Pill Form or Oral Spray May Ease Some MS Symptoms; Little Evidence Other Complementary or Alternative Therapies Work 03.24.2014
Do Obesity, Birth Control Pills Raise Risk of Multiple Sclerosis? 02.27.2014
Antibody May Be Detectable in Blood Years Before MS Symptoms Appear 02.21.2014
Could a Vaccine Help Ward off MS? 12.04.2013
Study: Measuring Walking Speed May Paint Picture of MS Progression 10.30.2013
MS May Not Be As Rare As Thought in African-Americans 05.06.2013
Massachusetts Researcher Receives Award for MS Research 03.25.2013
Can Hormone Help Treat Multiple Sclerosis Long-Term? 03.10.2013
Early Detection of MS Treatment Complication May Improve Survival 03.10.2013
People with MS-Related Memory and Attention Problems Have Signs of Extensive Brain Damage 03.06.2013
Oxford Neurologist Awarded Dystel Prize for MS Research 03.01.2013
AAN Releases List of Five Tests and Procedures You Should Question With Your Doctor 02.21.2013
Obesity May Increase Risk of MS in Children and Teens 01.30.2013
Eyes May Provide a Look into Multiple Sclerosis Progression 12.24.2012
Study: High Vitamin D Levels in Pregnancy May Protect Mother More Than Baby Against Multiple Sclerosis 11.19.2012
Stress Management Training May Help Reduce Disease Activity in MS 07.11.2012
Study: Botulinum Toxin a Shot in the Arm for Preventing MS Tremor 07.02.2012
University of Rochester Researcher Awarded $263,622 for Multiple Sclerosis Research 04.25.2012
Study: Use of Drug Following First Sign of Possible MS Reduces Likelihood of Progression to MS 04.19.2012
Pill Reduced Number of MS Lesions in Phase II Trial 04.16.2012
Past Pregnancies Linked to Reduced MS Risk in Women 03.07.2012
Cleveland Clinic Neurologist Awarded Dystel Prize for MS Research 02.21.2012
High-Dose Vitamin D May Not Be Better than Low-Dose Vitamin D in Treating MS 10.24.2011
Study: MS Drugs Help, But Come at High Cost 07.20.2011
Poor Bone Health May Start Early in People with Multiple Sclerosis 07.11.2011
Study: Breastfeeding Does Not Protect Against MS Relapses 07.06.2011
Can Stress Increase the Risk of Multiple Sclerosis? 05.30.2011
Vitamin D Levels Low in African-Americans with Multiple Sclerosis 05.23.2011
Study: Common Virus + Low Sunlight Exposure May Increase Risk of MS 04.18.2011
University of Pennsylvania Researcher Awarded $240,000 for Multiple Sclerosis Research 04.13.2011
Oral Drug for MS Significantly Reduces Disease Activity and Slows Disability 04.11.2011
Mayo Clinic Researcher Receives AAN’s Dystel Prize for Multiple Sclerosis Research 03.31.2011
Marijuana Use May Hurt Intellectual Skills in MS Patients 03.28.2011
Stem Cells May Show Promise for People with Rapidly Progressing MS 03.21.2011
Warm Weather May Hurt Thinking Skills in People with MS 02.17.2011
Sun Exposure, Vitamin D May Lower Risk of Multiple Sclerosis 02.07.2011
AAN Guideline: Plasma Exchange Effective in Treating Severe MS Relapses, Neuropathies 01.17.2011
Last Call for Entries: Public Asked to Submit Videos to 2011 Neuro Film Festival 01.11.2011
Women with MS More Likely to Have MS-Related Gene Than Men 01.05.2011
Holiday Recipe Help for People with Trouble Smelling and Tasting Food 12.16.2010
Mindfulness Meditation May Ease Fatigue, Depression in Multiple Sclerosis 09.27.2010
Multiple Sclerosis Activity Changes with the Seasons 08.30.2010
Gene Variant May Increase Severity of MS 08.02.2010
Can Mental Activity Protect Against Memory Problems in MS? 06.14.2010
New Treatment Helps Control Involuntary Crying and Laughing – Common in MS, ALS Patients 04.13.2010
AAN Foundation Awards $240,000 Brain Research Award to Mayo Clinic Researcher 04.13.2010
Actress Teri Garr Hosts New Video for MS Patients 04.08.2010
Does Smoking Compound Other MS Risk Factors? 04.07.2010
Yale Researcher Receives AAN’s Dystel Prize for Multiple Sclerosis Research 03.30.2010
Drinking Milk During Pregnancy May Lower Baby’s Risk of MS 02.09.2010
Good News on Multiple Sclerosis and Pregnancy 11.18.2009
Teenage Obesity Linked to Increased Risk of MS 11.09.2009
What Part Do Relapses Play in Severe Disability for People with MS? 11.04.2009
Cigarettes, Not Swedish Snuff Linked to Increased Risk of MS 08.31.2009
Smoking Linked to Increased Brain Lesions and Brain Shrinkage in MS 08.17.2009
Cognitive Testing, Gender and Brain Lesions May Predict MS Disease Progression Risk 07.29.2009
Risk of Leukemia with Multiple Sclerosis Drug Higher Than Thought 04.30.2009
Adding Steroid Drug to MS Treatment May Reduce Disease Activity 04.30.2009
Multiple Sclerosis Associated with Lower Cancer Risk 03.30.2009
Young Smokers Increase Risk for Multiple Sclerosis 02.20.2009
Can Breastfeeding Reduce Multiple Sclerosis Relapses? 02.19.2009
If MRI Shows Signs of MS, Will the Disease Develop? 12.10.2008
Obesity, Other Health Problems Delay MS Diagnosis 10.29.2008
Majority of Children Vaccinated Against Hepatitis B Not at Increased Risk of MS 09.25.2008
MS Can Affect Children’s IQ, Thinking Skills 05.12.2008
AAN Foundation and National Multiple Sclerosis Society Honor Boston Researcher 04.16.2008
Oral Drug, FTY720, Reduces Disease Activity in Multiple Sclerosis 04.15.2008
Smoking Marijuana Impairs Cognitive Function in MS Patients 02.13.2008
Smoking Has No Effect on Progression of Multiple Sclerosis 10.08.2007
Disease Activity Increases After MS Patients Stop Drug 09.12.2007
Childhood Sun Exposure May Lower Risk of MS 07.23.2007
New Clue Why MS Affects African Americans Differently than Caucasians 07.02.2007
Men and Women Equally Transmit Genetic Risk of MS to Their Children 06.27.2007
Studies Suggest Investigational Agent Reduces Disease Activity in MS 05.01.2007
Over Time, More Women Are Developing MS Than Men 04.26.2007
Philadelphia Researcher Awarded by AAN Foundation for Pediatric MS Research 04.23.2007
MS Drug Helps Reduce Vision Loss 04.16.2007
AAN Experts Available to Speak on Brain Injury, Sleep Awareness, MS 02.13.2007
‘Benign’ MS May Not Be So Benign 02.12.2007
Family Members with MS Likely to Share Onset Age, but Not Disease Severity 01.29.2007
Public Leadership in Neurology Award Honors Cuba Gooding, Jr., for Multiple Sclerosis Awareness Efforts 04.01.2006
Men With Multiple Sclerosis May Benefit From Testosterone Treatment 03.24.2006
Early Treatment Delays Multiple Sclerosis Progression 03.24.2006
University of Arizona Professor Emeritus to be Awarded the Dystel Prize for MS Research 03.23.2006
Drug May Help MS Patients with Laughing, Crying Spells 04.14.2005
Alzheimer’s Drug Improves Memory of MS Patients 11.08.2004
Hepatitis B vaccine may be associated with increased risk of multiple sclerosis 09.13.2004
Alzheimer’s Drug Improves Memory, Cognition in MS Patients 04.26.2004
Stress of Losing a Child Increases Risk of MS 03.08.2004
Taking Vitamin D Supplements Lowers Risk of Multiple Sclerosis 01.12.2004
Smoking Increases Risk of Multiple Sclerosis 10.27.2003
Guideline: MRIs Help Diagnose Multiple Sclerosis Faster 09.08.2003
Cholesterol-Lowering Drug Effective in Treating Most Common Form of MS 03.31.2003
Cholesterol Fighting Drugs May Also Have Protective Effects Against Multiple Sclerosis 10.07.2002
Risks of Cardiac Problems from Mitoxantrone in Treating MS Outlined 09.23.2002
Jury's Still Out on Use of Marijuana Derivative for MS 05.13.2002
Initial Chemotherapy Treatment Reduces Relapses in MS Patients 04.17.2002
Stem Cell Transplants May Be Effective for MS Patients 04.16.2002
Study Confirms Seasonal Fluctuation in Immunity-generating Cells Among MS Patients 04.08.2002
New Imaging Tests Shed Light on Brain Matter Changes in Relatives of MS Patients 01.21.2002
Cooling Vest Improves Symptoms for MS Patients 09.10.2001
New Marker for Disease Activity in Multiple Sclerosis 05.21.2001
Driving Abilities are Inhibited in Some People with MS 04.23.2001
MS Patients Should Get Flu Shots 04.09.2001
Study Ties Gene to Faster Progression of MS Symptoms 02.12.2001
Neurology Today
Imaging Tracks Fibrinogen Activity in MS Brain Inflammation 01.17.2013
NEWS FROM THE AMERICAN NEUROLOGICAL ASSOCIATION ANNUAL MEETING: Alemtuzumab Phase 3 Results: Will Superior Efficacy Overcome Safety Concerns for Early Treatment? 11.01.2012
Two Distinct RNA Profiles In Early Stage MS Show Differences in Disease Activity 10.18.2012
Amyloid Beta Reverses MS-like Disease in Mice. Is It Time to Re-evaluate Amyloid Elsewhere? 09.20.2012
Interferon Found Not to Slow MS Disability Progression 09.06.2012
Serum Levels of Antibodies to a Potassium Channel Found Higher in People with MS 09.06.2012
Fatty Acids Quell Myelin Inflammation in MS model 07.05.2012
Levels of Risk Identified for MS Patients Taking Natalizumab 07.05.2012
NEWS FROM THE AAN ANNUAL MEETING: For MS Patients, No Additive Benefit Found in Combining Glatiramer Acetate and Interferon Beta-1A 07.05.2012
Citing Possible Heart Risks, FDA Recommends Increased Monitoring, Tighter Indications, for MS Patients Prescribed Fingolimod 06.21.2012
News from the AAN Annual Meeting: Novel Agent Reduces MS. Lesions in Early Trial 06.07.2012
In the Field: John Dystel Prize for MS Research: Richard M. Ransohoff, MD: A ‘Neuro-Guy in the Chemokine Field’ Tackles MS 05.03.2012
Health Officials Launch Investigation in Deaths of Patients Taking Fingolimod 02.16.2012
A Game-Changer in MS Pathogenesis: New Evidence for Early Cortical Inflammation as Primary Target for Therapy 01.19.2012
Ocrelizumab Succeeds in Phase 2 Trial, Broadening the MS Treatment Landscape 11.17.2011
A New Oral Drug for MS: How Does it Compare? 11.03.2011
News from the ANA Annual Meeting: MS Death Rate Lower with Early Interferon Use, Study Shows 11.03.2011
MS-Like Disease in Monkeys is Caused by New Virus: Opening Up New Therapeutic Targets 08.04.2011
Skyrocketing MS Drug Prices Hit Patients Hard, Prompting Compliance Problems 04.21.2011
News from the AAN Annual Meeting: Fingolimod Heart Effects are Mild, Transient, and Usual Asymptomatic 04.21.2011
Revised McDonald Criteria Make Diagnosis Simpler, Faster 04.21.2011
New Clues to Remyelination Provide Potential Targets for MS Therapy 04.07.2011
New Data to Support Neurofilament Levels as A Biomarker in Multiple Sclerosis 03.17.2011
Transdermal Myelin Down-Regulates Autoimmunity for MS Patients 01.06.2011
FDA Approves First MS Oral Therapy 10.21.2010
Atorvastatin Fails to Meet Primary Objective for Relapse Reduction in Clinically Isolated Syndrome: Researchers Suggest Exploring It as Add-on MS Therapy 10.21.2010
Is a ‘Holiday’ from Natalizumab Safe for MS Patients? 10.07.2010
Antibody Test Emerges as Best Way to Find JC Virus in MS Patients 10.07.2010
Study Support MxA as Potential Blood Biomarker for MS Relapse 10.07.2010
Two New Papers Question MS-CCSVI Theory 10.07.2010
MS Experts Highlight Favorite Papers on MS — From Predicting the Course of Disease to Comparing New to Standard Therapies 06.03.2010
Vitamin D in High Doses Found Safe — with Potential Benefits for MS 06.03.2010

  Print-friendly Version

Multiple Sclerosis

New Website Provides Latest Information on MS Therapies as They Emerge

An unpredictable disease of the central nervous system, multiple sclerosis (MS) can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted.  Many investigators believe MS to be an autoimmune disease -- one in which the body, through its immune system, launches a defensive attack against its own tissues. In the case of MS, it is the nerve-insulating myelin that comes under assault. Such assaults may be linked to an unknown environmental trigger, perhaps a virus.Most people experience their first symptoms of MS between the ages of 20 and 40; the initial symptom of MS is often blurred or double vision, red-green color distortion, or even blindness in one eye.  Most MS patients experience muscle weakness in their extremities and difficulty with coordination and balance.  These symptoms may be severe enough to impair walking or even standing. In the worst cases, MS can produce partial or complete paralysis.  Most people with MS also exhibit paresthesias, transitory abnormal sensory feelings such as numbness, prickling, or "pins and needles" sensations.  Some may also experience pain.  Speech impediments, tremors, and dizziness are other frequent complaints. Occasionally, people with MS have hearing loss. Approximately half of all people with MS experience cognitive impairments such as difficulties with concentration, attention, memory, and poor judgment, but such symptoms are usually mild and are frequently overlooked.  Depression is another common feature of MS.

Treatment

There is as yet no cure for MS. Many patients do well with no therapy at all, especially since many medications have serious side effects and some carry significant risks.  However, three forms of beta interferon (Avonex, Betaseron, and Rebif) have now been approved by the Food and Drug Administration for treatment of relapsing-remitting MS. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability. When attacks do occur, they tend to be shorter and less severe.  The FDA also has approved a synthetic form of myelin basic protein, called copolymer I (Copaxone), for the treatment of relapsing-remitting MS. Copolymer I has few side effects, and studies indicate that the agent can reduce the relapse rate by almost one third.  Other FDA approved drugs to treat relapsing forms of MS in adults include teriflunomide and dimethyl fumarate.  An immunosuppressant treatment, Novantrone (mitoxantrone), is approved by the FDA for the treatment of advanced or chronic MS.  The FDA has also approved dalfampridine (Ampyra) to improve walking in individuals with MS.One monoclonal antibody, natalizumab (Tysabri), was shown in clinical trials to significantly reduce the frequency of attacks in people with relapsing forms of MS and was approved for marketing by the U.S. Food and Drug Administration (FDA) in 2004.  However, in 2005 the drug’s manufacturer voluntarily suspended marketing of the drug after several reports of significant adverse events.  In 2006, the FDA again approved sale of the drug for MS but under strict treatment guidelines involving infusion centers where patients can be monitored by specially trained physicians. While steroids do not affect the course of MS over time, they can reduce the duration and severity of attacks in some patients.  Spasticity, which can occur either as a sustained stiffness caused by increased muscle tone or as spasms that come and go, is usually treated with muscle relaxants and tranquilizers such as baclofen, tizanidine, diazepam, clonazepam, and dantrolene. Physical therapy and exercise can help preserve remaining function, and patients may find that various aids -- such as foot braces, canes, and walkers -- can help them remain independent and mobile.  Avoiding excessive activity and avoiding heat are probably the most important measures patients can take to counter physiological fatigue.  If psychological symptoms of fatigue such as depression or apathy are evident, antidepressant medications may help.  Other drugs that may reduce fatigue in some, but not all, patients include amantadine (Symmetrel), pemoline (Cylert), and the still-experimental drug aminopyridine. Although improvement of optic symptoms usually occurs even without treatment, a short course of treatment with intravenous methylprednisolone (Solu-Medrol) followed by treatment with oral steroids is sometimes used.

Prognosis

A physician may diagnose MS in some patients soon after the onset of the illness. In others, however, doctors may not be able to readily identify the cause of the symptoms, leading to years of uncertainty and multiple diagnoses punctuated by baffling symptoms that mysteriously wax and wane.  The vast majority of patients are mildly affected, but in the worst cases, MS can render a person unable to write, speak, or walk.  MS is a disease with a natural tendency to remit spontaneously, for which there is no universally effective treatment.

Research

The National Institute of Neurological Disorders and Stroke (NINDS) and other institutes of the National Institutes of Health (NIH) conduct research in laboratories at the NIH and also support additional research through grants to major medical institutions across the country.  Scientists continue their extensive efforts to create new and better therapies for MS.  One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability. When attacks do occur, they tend to be shorter and less severe.  In addition, there are a number of treatments under investigation that may curtail attacks or improve function.  Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models.In 2001, the National Academies/Institute of Medicine, a Federal technical and scientific advisory agency, prepared a strategic review of MS research. To read or download the National Academies/Institute of Medicine report, go to: "Multiple Sclerosis: Current Status and Strategies for the Future."

View a list of studies currently seeking patients.

View more studies on this condition.

Read additional information from Medline Plus.

Organizations

National Ataxia Foundation (NAF)

Encourages and supports research into the hereditary ataxias, a group of chronic and progressive neurological disorders affecting coordination. Sponsors chapters and support groups throughout the U.S.A. and Canada. Publishes a quarterly newsletter and educational literature on the various forms of ataxia.

2600 Fernbrook Lane North
Suite 119
Minneapolis, MN 55447-4752
Tel: 763-553-0020
Fax: 763-553-0167

Clearinghouse on Disability Information

Special Education & Rehabilitative Services Communications & Customer Service Team
550 12th Street, SW, Rm. 5133
Washington, DC 20202-2550
Tel: 202-245-7307 202-205-5637 (TTD)
Fax: 292024507636

American Autoimmune Related Diseases Association

National organization that works to alleviate suffering and the socioeconomic impact of autoimmunity. Dedicated to the eradication of autoimmune diseases through fostering and facilitating collaboration in the areas of education, research, and patient services.

22100 Gratiot Avenue
Eastpointe, MI 48021-2227
Tel: 586-776-3900 800-598-4668
Fax: 586-776-3903

National Organization for Rare Disorders (NORD)

Federation of voluntary health organizations dedicated to helping people with rare "orphan" diseases and assisting the organizations that serve them. Committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service.

55 Kenosia Avenue
Danbury, CT 06810
Tel: 203-744-0100 Voice Mail 800-999-NORD (6673)
Fax: 203-798-2291

Myelin Repair Foundation

Focused on accelerating the discovery and development of myelin repair therapeutics for multiple sclerosis to globally impact the way medical science is conducted by shortening the time to market for new medicines for patients.

18809 Cox Avenue
Suite 190
Saratoga, CA 95070
Tel: 408-871-2410

Well Spouse Association

International non-profit, volunteer-based organization whose mission is to provide emotional support to, raise consciousness about, and advocate for the spouses/partners of the chronically ill and/or disabled.

63 West Main Street
Suite H
Freehold, NJ 07728
Tel: 800-838-0879 732-577-8899
Fax: 732-577-8644

Multiple Sclerosis Association of America

National, non-profit organization dedicated to enhancing the quality of life for those affected by multiple sclerosis. MSAA provides ongoing support and direct services to individuals with MS and their families and works to promote a greater understanding of the needs and challenges of those who face physical obstacles.

706 Haddonfield Road
Cherry Hill, NJ 08002
Tel: 856-488-4500 800-532-7667
Fax: 856-661-9797

Multiple Sclerosis Foundation

Dedicated to helping people with MS, the Multiple Sclerosis Foundation offers a wide array of free services including: national toll-free support, educational programs, homecare services, support groups, assistive technology programs, publications, a comprehensive website, and more programs to improve the quality of life for those affected by MS.

6520 North Andrews Avenue
Ft. Lauderdale, FL 33309-2130
Tel: 954-776-6805 888-MSFOCUS (673-6287)
Fax: 954-351-0630

National Rehabilitation Information Center (NARIC)

8201 Corporate Drive
Suite 600
Landover, MD 20785
Tel: 301-459-5900/301-459-5984 (TTY) 800-346-2742
Fax: 301-562-2401

National Multiple Sclerosis Society

Funds research, helps families stay together, provides accurate and up-to-date information, helps with employment issues, offers free counseling, runs self-help groups, advocates for people with disabilities, and provides referrals to medical professionals.

733 Third Avenue
3rd Floor
New York, NY 10017-3288
Tel: 800-344-4867 (800-FIGHT-MS)
Fax: 212-986-7981

Paralyzed Veterans of America (PVA)

Non-profit organization dedicated to serving the needs of its members—more than 19,000 veterans paralyzed by spinal cord injury or disease, as well as caregivers and others affected by these disabilities—through advocacy, education, and research programs.

801 18th Street, NW
Washington, DC 20006-3517
Tel: 202-USA-1300 (872-1300) 800-555-9140
Fax: 202-785-4452

Accelerated Cure Project for Multiple Sclerosis

National nonprofit organization dedicated to accelerating efforts toward a cure for MS. Researchers have access to online resources and the ACP Repository of highly characterized biosamples.

460 Totten Pond Rd. Suite 420
Waltham, MA 02451
Tel: 781-487-0008
Fax: 781-487-0009

<< Back